Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KLA Corp. (KLAC) vs Nuwellis Inc (NUWE) Price & Performance

Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

KLA Corp. vs Nuwellis Inc — how do they compare? KLA Corp. trades at $203.65 (market cap $251.82B), while Nuwellis Inc trades at $1.49 (market cap $522.76K). The key difference: KLA Corp. is far larger — about 481712.4× Nuwellis Inc's market cap, and KLA Corp. pays a 0.48% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.

KLACNUWE
Market Cap
$251.82B$522.76K
Sector
TechnologyTechnology
52-Week High
$301.71$220.50
52-Week Low
$84.39$1.42
Enterprise Value
$253.07B-$1.29M
Dividend Yield
0.48%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KLA Corp.

KLA Corporation (KLAC) trades at $198.11, up 2.53% today, with a neutral technical signal despite bullish moving averages. The stock shows strong fundamentals, including a 35.57% net income margin and consistent earnings beats, with Q3 2026 EPS expected at $1.17. Recent corporate actions include a 1:10 stock split and a $2.30 dividend, while cash flow remains positive at $101.78M in 2025. Analyst sentiment is optimistic, with a $246.93 consensus price target implying significant upside.

The outlook for KLAC is positive, driven by AI-driven semiconductor demand and robust profitability, but risks include high valuation multiples and market volatility. Investment opportunities center on growth in advanced packaging, with Wall Street largely bullish; however, investors should monitor competitive pressures and economic cycles that could impact the chip equipment sector.

Nuwellis Inc

NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.

The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About KLA Corp.

KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.

Read more on KLAC

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE